The
metastasis and angiogenesis of
breast cancer has always been a difficult problem for treatment. It has recently been discovered that
Von Willebrand Factor (vWF), in addition to hemostasis, also plays a role in
tumor metastasis and angiogenesis. We noticed that besides endothelial cells,
breast cancer cells (MDA-MB-231 and MCF-7) could also express vWF. In vitro experiments showed that knocking down vWF inhibited
breast cancer cell
metastasis. And we found that overexpression of vWF significantly promoted
VEGF-A-dependent vascular proliferation in vitro by activating the PI3K/Akt signaling pathway. Further studies indicated that inhibition of PI3K/Akt signaling pathway up-regulated the expression of miR-205-5p, and miR-205-5p could bind to the
3'UTR region of
VEGF-A to hinder the production of
VEGF-A. Furthermore, when a spontaneous lung
metastasis model was established in Balb/c female mice, knockdown of vWF in 4 T1 cells resulted in a decrease in
tumor blood vessel density and effectively inhibited lung
metastasis, accompanied by a decrease in the expression level of
VEGF-A and an increase in the expression level of miR-205-5p. In summary, our findings provide experimental evidence that overexpression of vWF in
breast cancer cells down-regulates the expression of miR-205-5p and up-regulates the expression of
VEGF-A through the PI3K/Akt signaling pathway, thereby promoting
tumor angiogenesis and
metastasis.